Piio Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Piio's estimated annual revenue is currently $580k per year.(i)
  • Piio's estimated revenue per employee is $72,500

Employee Data

  • Piio has 8 Employees.(i)
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15780M383990%$2.5M$247.7B
#2
$0.1M6-45%$41MN/A
#3
$0.8M19N/AN/AN/A
#4
$2.2M22N/AN/AN/A
#5
$35M602N/AN/AN/A
#6
$15M183N/AN/AN/A
#7
$9M69N/AN/AN/A
#8
$2M20N/AN/AN/A
#9
$3.7M32N/AN/AN/A
#10
N/A13N/AN/AN/A
#11
$0.2M4N/AN/AN/A
#12
$0.9M10N/AN/AN/A
#13
$0.4M6N/AN/AN/A
#14
$0.2M3N/AN/AN/A
#15
$5.3M46N/AN/AN/A
#16
$19M131N/AN/AN/A
#17
$61M3310%$7MN/A
#18
$4.2M24N/AN/AN/A
#19
$1.7M12N/AN/AN/A
#20
$2.6M26N/AN/AN/A
Add Company

What Is Piio?

keywords:saas

N/A

Total Funding

8

Number of Employees

$580k

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Piio News

2022-04-17 - Study finds male sex hormones as new target for cancer immunotherapy

The study was led by researchers in the Pelotonia Institute for Immuno-Oncology (PIIO) at The Ohio State University Comprehensive Cancer...

2022-04-13 - Study reveals male sex hormones are new targets for cancer ...

Zihai Li, cancer immunologist, medical oncologist and founding director of the PIIO at OSUCCC – James. Androgens are sex hormones more highly...

2022-04-13 - New Cancer Immunotherapy Target: Male Sex Hormone?

... for Immuno-Oncology (PIIO) at The Ohio State University Comprehensive Cancer ... and founding director of the PIIO at OSUCCC—James.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.6M8-20%N/A
#2
$0.1M814%$11.8M
#3
$0.1M80%$8.6M
#4
$0.6M8-90%N/A
#5
$0.6M8N/AN/A